Glycemic biomarkers in children with drug-resistant epilepsy on various types of ketogenic diet therapies: A cross-sectional study.

Lip-Yuen TengVanessa Wan-Mun LeeSumitha MurugesuJun-Xiong LeeNur Sakinah IbrahimMohd Fatahudin IshakAhmad Rithauddin MohamedTeik-Beng Khoo

Published in: Epilepsia (2022)

HbA1c could potentially be useful for monitoring KD adherence or, indirectly, systemic ketosis in nondiabetic children on KD for drug-resistant epilepsy. Plasma acylcarnitine and mGKI could be important biomarkers in the management of KD therapy.

Keyphrases

drug resistant
multidrug resistant
acinetobacter baumannii
young adults
physical activity
type diabetes
weight loss
stem cells
glycemic control
metabolic syndrome
risk factors
pseudomonas aeruginosa
skeletal muscle
adipose tissue
bone marrow
replacement therapy